SCHEMBL2406176

SCHEMBL2406176

Cc1ccc(-c2cnccn2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
CYP2D6 P10635 1/20 0.47
CYP19A1 P11511 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PIK3CD O00329 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
PI4KA P42356 1/20 0.46
PIK3CG P48736 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
CHEK1 O14757 1/20 0.46
PIM2 Q9P1W9 2/20 0.43
PIM1 P11309 1/20 0.43
RAB9A P51151 3/20 0.43
KDM4E B2RXH2 1/20 0.42
MAPT P10636 2/20 0.41
USP2 O75604 1/20 0.41
WNT3A P56704 1/20 0.40
CYP2A6 P11509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16385300 0.84 HSD17B1 (0.47) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL3346933 0.84 PIK3CD (0.50) NPC1CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL7399345 0.84 CYP2D6 (0.44) NPC1CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL2559473 0.84 KMO (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL2409087 0.84 PIM1 (0.46) NPC1CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL24732450 0.81 CYP2D6 (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL16385234 0.81 RAB9A (0.53) NPC1CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL25480188 0.81 CYP2D6 (0.45) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL18471236 0.80 CYP1A2 (0.44) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL21241437 0.80 S1PR1 (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212968-A1 PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212968-A1 PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES HCRTR2, HCRTR1, HRH3 NPC1 1540/4885CYP2D6 1512/4885CYP19A1 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.